Treace Medical Concepts (TMCI)
(Delayed Data from NSDQ)
$11.00 USD
+0.29 (2.71%)
Updated May 3, 2024 04:00 PM ET
After-Market: $11.01 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Bottom 40% (150 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.29 | 1.57 | 9.99 |
Current Quarter Estimate | -0.30 | 3.93 | 57.00 |
Year Ago Quarter Estimate | -0.23 | 3.85 | 52.54 |
Next Quarter Estimate | -0.27 | 3.92 | 61.00 |
Next Year Estimate | -0.79 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -12.35 | 13.60 | 15.67 |
Next Year | 13.19 | 22.60 | 9.31 |
Last 5 Years | NA | 10.00 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 29.13 |
Price/Book (MRQ) | 4.92 | 2.35 |
Price/Cash Flow (MRFY) | NA | 15.02 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -26.47% | 11.04% |
Return on Equity (TTM) | -33.96% | 12.91% |
Debt to Equity (MRQ) | NA | 12.47 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.